- Home
- RLMD vs RXST Comparison
RLMD vs RXST Comparison
Compare RLMD & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- RXST
- Stock Information
- Founded
- RLMD 2004
- RXST 1997
- Country
- RLMD United States
- RXST United States
- Employees
- RLMD N/A
- RXST N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RLMD Health Care
- RXST Health Care
- Exchange
- RLMD Nasdaq
- RXST Nasdaq
- Market Cap
- RLMD 289.7M
- RXST 307.3M
- IPO Year
- RLMD N/A
- RXST 2021
- Fundamental
- Price
- RLMD $3.98
- RXST $9.75
- Analyst Decision
- RLMD Hold
- RXST Hold
- Analyst Count
- RLMD 2
- RXST 11
- Target Price
- RLMD $1.00
- RXST $11.20
- AVG Volume (30 Days)
- RLMD 1.8M
- RXST 714.7K
- Earning Date
- RLMD 11-13-2025
- RXST 11-05-2025
- Dividend Yield
- RLMD N/A
- RXST N/A
- EPS Growth
- RLMD N/A
- RXST N/A
- EPS
- RLMD N/A
- RXST N/A
- Revenue
- RLMD N/A
- RXST $142,085,000.00
- Revenue This Year
- RLMD N/A
- RXST N/A
- Revenue Next Year
- RLMD N/A
- RXST $6.71
- P/E Ratio
- RLMD N/A
- RXST N/A
- Revenue Growth
- RLMD N/A
- RXST 10.75
- 52 Week Low
- RLMD $0.24
- RXST $6.32
- 52 Week High
- RLMD $4.34
- RXST $47.89
- Technical
- Relative Strength Index (RSI)
- RLMD 78.00
- RXST 58.46
- Support Level
- RLMD $2.42
- RXST $8.24
- Resistance Level
- RLMD $2.86
- RXST $10.77
- Average True Range (ATR)
- RLMD 0.43
- RXST 0.74
- MACD
- RLMD 0.15
- RXST 0.13
- Stochastic Oscillator
- RLMD 82.19
- RXST 61.15
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.